Other recorded roll call
SB883
Passed
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Passed
Senate
April 10, 2025
23Yea
7Nay
0Not voting
1Absent
Republicans (20)
100% yea among members casting a yea or nay vote (19–0).
Democrats (11)
36% yea among members casting a yea or nay vote (4–7).
Source provenance
- LegiScan roll-call ID
- 1544878
- LegiScan bill ID
- 1937493
- Session ID
- 2160
- Individual records rendered
- 31
- Source file
var/states/texas/source/legiscan/2160-8caaa099665d/vote/1544878.json- Package observed
- 2026-07-17T02:14:58+00:00
- Final-action classification
- Did not match the final-vote patterns; retained as part of the complete bill record.